Jyong Biotech Ltd. — Investor Relations & Filings
Filings indexed
64
across all filing types
Latest filing
2026-05-14
Annual Report
Country
US
United States of America
Listing
US
MENS
Jyong Biotech Ltd. is a science-driven biotechnology company focused on the development and commercialization of plant-derived drugs for urinary system diseases. The company's primary therapeutic areas include benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). Its lead drug candidate, MCS-2, is a botanical formulation that has completed late-stage (Phase III) clinical trials. Leveraging a proprietary research and development platform, Jyong Biotech aims to advance its pipeline of innovative botanical medicines to address unmet medical needs in urology for a global patient population.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ANNUAL REPORT | 2026-05-14 | English | |
| 6-K Filing | 2026-02-06 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-09 | English | |
| SP 15D2 | 2025-06-30 | English | |
| REPORT OF FOREIGN PRIVATE ISSUER | 2025-06-18 | English | |
| PROSPECTUS | 2025-06-18 | English |
Browse filings by year
4 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
3 filings
| |||||
| 46352458 | ANNUAL REPORT | 2026-05-14 | English | ||
| 32247838 | 6-K Filing | 2026-02-06 | English | ||
| 13627629 | REPORT OF FOREIGN PRIVATE ISSUER | 2026-01-09 | English | ||
|
2025
12 filings
| |||||
| 13627630 | SP 15D2 | 2025-06-30 | English | ||
| 13627631 | REPORT OF FOREIGN PRIVATE ISSUER | 2025-06-18 | English | ||
| 13627632 | PROSPECTUS | 2025-06-18 | English | ||
| 13627633 | Regulatory Filings 2025 | 2025-06-17 | English | ||
| 13627634 | Regulatory Filings 2025 | 2025-06-16 | English | ||
| 13627635 | FOR REGISTRATION OF CERTAIN CLASSES | 2025-06-12 | English | ||
| 13627637 | Regulatory Filings 2025 | 2025-06-12 | English | ||
| 13627636 | Regulatory Filings 2025 | 2025-06-12 | English | ||
| 13627638 | REGISTRATION STATEMENT | 2025-06-06 | English | ||
| 13627639 | POST-EFFECTIVE AMENDMENT | 2025-04-23 | English | ||
| 13627641 | Regulatory Filings 2025 | 2025-04-01 | English | ||
| 13627640 | Regulatory Filings 2025 | 2025-03-28 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Altimmune, Inc.
Clinical-stage biopharma developing peptide therapeutics fo…
|
ALT | US | Manufacturing |
|
Alto Neuroscience, Inc.
Develops precision medicines for neuropsychiatric condition…
|
ANRO | US | Manufacturing |
|
ALUMIS INC.
Clinical-stage biopharma developing precision medicines for…
|
ALMS | US | Manufacturing |
|
Alvotech Holdings S.A
A biotechnology company developing and manufacturing biosim…
|
ALVO | LU | Manufacturing |
|
ALX ONCOLOGY HOLDINGS INC
Clinical-stage immuno-oncology company developing therapies…
|
ALXO | US | Manufacturing |
|
Alzamend Neuro, Inc.
Develops treatments for neurodegenerative diseases and psyc…
|
ALZN | US | Manufacturing |
|
Alzinova AB
Clinical-stage biopharma developing immunotherapies for Alz…
|
ALZ | SE | Manufacturing |
|
Amanta Healthcare Limited
Manufactures sterile liquid formulations using advanced Blo…
|
AMANTA | IN | Manufacturing |
|
AMARIN CORP PLC\UK
Develops and commercializes therapeutics to improve cardiov…
|
AMRN | US | Manufacturing |
|
Ambalal Sarabhai Enterprise Ltd.
Manufactures pharmaceuticals, APIs, fine chemicals, and dia…
|
AMBALALSA | IN | Manufacturing |
Jyong Biotech Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31202/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31202 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31202 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31202 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31202}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Jyong Biotech Ltd. (id: 31202)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.